A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy
Clinical trial NCT04002310 · TERMINATED
Trial details
- NCT number
- NCT04002310
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-26
- Primary completion
- 2022-08-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.